Danaher (NYSE: DHR)
Danaher Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Danaher Company Info
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
News & Analysis
Here's Why Danaher Stock Surged Today
The biotechnology, diagnostics, and life sciences company looks set to return to its long-term growth rate.
2 Buys and 1 Sell From Al Gore's Investment Company
An industrial software company, a positioning and workflow company, and a leading life science, bioprocessing, and diagnostics company make up a list of stocks traded by Generation Investment Management.
Why Shares of Danaher Are Down Monday
The conglomerate has completed the spinoff of its environmental and applied solutions segment into a new company, Veralto.
These 3 Stocks Might Be Getting a Little Too Expensive
On a risk/reward basis, they aren't a great value right now, but these are excellent stocks to watch and wait for a better entry point.
Stock Market Sell-Off: Is Danaher Stock a Buy?
The life sciences and diagnostics company's guidance is getting complicated.
Why a Strong Balance Sheet Matters: General Electric and Honeywell Investors Take Note
A comparison between the balance sheets of two industrial giants speaks volumes about the importance of a strong balance sheet.
5 Stocks Wall Street Thinks Could Soar
The featured stocks all trade at substantial discounts to analyst price targets.
Down 25% in 2022: Buy This High-Quality Stock on a Dip?
Danaher's long-term prospects are being ignored because of the near-term speculation around how long the pandemic will last.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.